My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Catabasis Pharmaceuticals (CATB)
NASDAQ:CATB
CATBCatabasis Pharmaceuticals

Catabasis Pharmaceuticals Stock Investors

Based on 473,701 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CATB
On average, investors allocate 3.70% of their portfolios to CATB
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 473,701 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CATB

3.6%
Last 7
Days
7.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CATB, out of 473,701 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CATB Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$8.36
Closed
0.00%
$0.00
Closed
0.00%
$8.36
Increased
0.69%
$8.60
Based on the activity of 40,856 investors who made their portfolios public
The table shows changes in CATB in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CATB Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AXSMAxsome Therapeutics
6.63%
1.98%
16.82%
$904.37M
Healthcare
ARAVAravive
3.11%
-2.90%
-10.91%
$85.13M
Healthcare
ARDXArdelyx
6.02%
-0.12%
-4.11%
$149.52M
Healthcare
LCTXLineage Cell Therapeutics
5.66%
-1.88%
-5.49%
$440.42M
Healthcare
NVAXNovavax
15.13%
0.22%
-0.11%
$20.15B
Healthcare
SRPTSarepta Therapeutics
4.20%
-0.72%
-4.35%
$6.25B
Healthcare
ZYNEZynerba Pharmaceuticals
3.72%
-1.29%
1.53%
$171.19M
Healthcare
SIOXSio Gene Therapies
1.77%
-0.85%
-0.74%
$151.72M
Healthcare
PRTKParatek Pharmaceuticals
3.72%
-1.55%
-2.23%
$269.83M
Healthcare
GBTGlobal Blood Therapeutics
4.78%
-0.07%
-1.64%
$1.88B
Healthcare
Based on the activity of 473,701 active portfolios
Open your Smart Portfolio

CATB Investor Analysis

CATB investors under 35

Under 35

49.8%
Last 30 days
Holdings Change
8.0%
of CATB holders
are under 35
Average Segment Performance
Monthly Return1.59%
Beta1.50
Dividend Yield5.19%
CATB investors between 35–55

Between 35–55

5.7%
Last 30 days
Holdings Change
68.0%
of CATB holders
are between 35–55
Average Segment Performance
Monthly Return1.81%
Beta1.61
Dividend Yield21.40%
CATB investors over 55

Over 55

15.8%
Last 30 days
Holdings Change
24.0%
of CATB holders
are over 55
Average Segment Performance
Monthly Return1.63%
Beta1.37
Dividend Yield5.76%
Overview of age group and performance of CATB stock investors
See who invests in CATB according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
TSE:TRYPTryp Therapeutics Inc
HAVLFHAVN Life Sciences
ENTBFEntheon Biomedical
FTRPField Trip Health
MCURFMind Cure Health

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis